Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
38.44
-0.28 (-0.72%)
At close: Aug 15, 2025, 12:49 PM
Cytokinetics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for CYTK stock have an median target of 74.5, with a low estimate of 41 and a high estimate of 84. The median target predicts an increase of 93.81% from the current stock price of 38.44.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 41 | 68.08 | 74.5 | 84 |
| Change | 6.66% | 77.11% | 93.81% | 118.52% |
Latest Analyst Insight Report
Needham has reaffirmed a Buy rating on Cytokinetic... Unlock content with Pro Subscription
Updated May 14, 2025
| Rating | Jan 25 | Feb 25 | Apr 25 | May 25 | Jun 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 6 | 5 | 7 | 6 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 8 | 7 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
77.13M
from 18.47M
Increased by 317.5%
Revenue Next Year
145.53M
from 77.13M
Increased by 88.7%
EPS This Year
-5.58
from -5.26
Increased by -6.1%
EPS Next Year
-5.64
from -5.58
Increased by -1.1%